Anixa Biosciences (ANIX) Intangibles (2014 - 2020)
Anixa Biosciences' (ANIX) quarterly Intangibles came in at $168000.0 in Q4 2020, up 301.19% quarter-over-quarter from $41875.0 in Q2 2019.
Analysis
Anixa Biosciences (ANIX) Intangibles (2014 - 2020) Analysis & Trends
Anixa Biosciences (ANIX) has reported Intangibles for 7 consecutive years, with $168000.0 the latest figure, recorded in Q4 2020.
- For the quarter ending Q4 2020, Intangibles changed N/A year-over-year to $168000.0; the trailing twelve-month figure through Oct 2020 stood at $168000.0 (changed N/A YoY), and the FY2020 full-year result was $168000.0, changed N/A from the prior year.
- Intangibles climbed to $168000.0 in Q4 2020 per ANIX's latest filing, from $41875.0 in the prior quarter.
- Across five years, Intangibles topped out at $2.3 million in Q1 2016 and bottomed at $41875.0 in Q2 2019.
- Historically, Intangibles has averaged $1.5 million across 5 years, with a median of $1.7 million in 2017.
- The sharpest annual moves came in 2016 and 2019: Intangibles declined 12.32% in 2016, then tumbled 97.35% in 2019.
- Over 5 years, Intangibles stood at $2.1 million in 2016, then slipped by 15.71% to $1.7 million in 2017, then sank by 52.03% to $837500.0 in 2018, then sank by 95.0% to $41875.0 in 2019, then surged by 301.19% to $168000.0 in 2020.
- According to Business Quant data, Intangibles over the past three periods registered $168000.0, $41875.0, and $167500.0 for Q4 2020, Q2 2019, and Q1 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn | 330.24 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | 62.10 Mn |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 2.55 Mn |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.35 Bn | 251.87 Mn | 30.61 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 5.31 Mn |
| 10 | Anixa Biosciences | 92.72 Mn | 92.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2020 | 168,000.00 |
| Apr 30, 2019 | 41,875.00 |
| Jan 31, 2019 | 167,500.00 |
| Oct 31, 2018 | 837,500.00 |
| Jul 31, 2018 | 1.50 Mn |
| Apr 30, 2018 | 1.58 Mn |
| Jan 31, 2018 | 1.66 Mn |
| Oct 31, 2017 | 1.75 Mn |
| Jul 31, 2017 | 1.83 Mn |
| Apr 30, 2017 | 1.91 Mn |
| Jan 31, 2017 | 1.99 Mn |
| Oct 31, 2016 | 2.07 Mn |
| Jul 31, 2016 | 2.15 Mn |
| Apr 30, 2016 | 2.23 Mn |
| Jan 31, 2016 | 2.32 Mn |
| Oct 31, 2015 | 2.40 Mn |
| Jul 31, 2015 | 2.48 Mn |
| Apr 30, 2015 | 2.56 Mn |
| Jan 31, 2015 | 2.64 Mn |
| Oct 31, 2014 | 2.72 Mn |